- AdventHealth
Central Florida is struggling with labor shortages like most of the nation. Investing in the workforce of the future now is crucial. Randy Haffner, president and CEO of AdventHealth Florida, and University of Central Florida President Alex Cartwright believe innovation, collaboration and lifelong learning will be powerful tools in solving this challenge. “We need to be a dynamic learning community,” Haffner said.
In this episode of the Inspiring Wholeness podcast, Haffner and Cartwright share the major investment they’re making to build a diverse talent pipeline in Central Florida and what role businesses can play.
Recent News
Kidney-tumor patients have an innovative new treatment option, first performed recently by a surgical team at AdventHealth Celebration.
Test Apple Podcast
As the Official Healthcare Provider of the 2024 NASCAR Chicago Street Race, we’re thrilled to support such a memorable experience with this amazing community.
The innovative new treatment targets and destroys tumors using sound beams, noninvasively and without the need for needles and incisions.
A summary of the article goes here. A summary of the article goes here. A summary of the article goes here. A summary of the article goes here.
The innovative new treatment targets and destroys tumors using sound beams, noninvasively and without the need for needles and incisions.
Dr. Corbin on the gut microbiome research study
A genetic test, originally conducted to help better understand her daughter's diagnosis, revealed Samantha Arceneaux carries a genetic variant that virtually guarantees she will develop an aggressive...
Under the leadership of investigator Guru Sonpavde, MD, AdventHealth’s Clinical Research Unit (CRU), a collaborative between the AdventHealth Cancer Institute and AdventHealth Research Institute, is...
The AdventHealth Research Institute recently launched two new clinical studies to better understand and address the needs of healthcare employees who work night shifts.
The CheckMate 901 Phase III clinical trial results, recently published in the New England Journal of Medicine, found that combining the programmed death 1 (PD1) inhibitor immunotherapy nivolumab with...
The new SMILE with Stella Tremonti Down Syndrome Clinic is the only lifespan program of its kind in the Southeast.